Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 44 | 124 | 44 | 171 | 44 |
| Gross Profit | 44 | 124 | 44 | 171 | 44 |
| Operating Expenses | 25,276 | 16,118 | 29,677 | 25,286 | 22,398 |
| Operating Income | -25,232 | -15,994 | -29,633 | -25,115 | -22,354 |
| Other Income | 489 | 58 | 949 | 2,540 | -71 |
| Pre-tax Income | -24,743 | -15,936 | -28,684 | -22,575 | -22,425 |
| Net Income Continuous | -24,741 | -15,936 | -28,684 | -22,575 | -22,420 |
| Net Income | $-24,746 | $-15,936 | $-28,684 | $-22,575 | $-22,430 |
| EPS Basic Total Ops | -0.41 | -0.27 | -0.51 | -0.41 | -0.44 |
| EPS Basic Continuous Ops | -0.41 | -0.27 | -0.51 | -0.41 | -0.43 |
| EPS Diluted Total Ops | -0.41 | -0.27 | -0.51 | -0.41 | -0.44 |
| EPS Diluted Continuous Ops | -0.41 | -0.27 | -0.51 | -0.41 | -0.43 |
| EBITDA(a) | $-24,211 | $-14,976 | $-28,863 | $-24,478 | $-21,706 |